AI is already running your supply chain. Are you confident in every decision it makes?
You’ve already invested in AI across planning, inventory, logistics, and supplier management. The question is whether those systems are delivering in real-world conditions.
Turing helps pharma supply chain leaders assess, stress-test, and refine existing AI workflows. We identify where models drift, where agent logic breaks under variability, and where automation can safely expand, without compromising compliance or control.
Meet us at LogiPharma to see how your AI stack holds up under operational pressure and where targeted improvements can unlock immediate ROI.
When: April 14-16, 2026
Where: Austria Center Vienna | Booth 124
Why AI Isn’t Delivering in Pharma Supply Chains
Across the industry, teams are investing in AI, but many initiatives stall before they deliver outcomes. Common barriers include:
- Pilot projects without operational anchors
- Siloed tools that don’t integrate with clinical workflows
- Lack of standards and interoperable data
- Insufficient evaluation and governance mechanisms
- Regulatory and compliance risk concern
- EMR data harmonization
AI delivers durable advantage only when performance, decisions, and outcomes are connected in a closed loop.
How Turing Delivers Production-Grade AI
We help teams evaluate and enhance the AI systems already embedded in critical workflows. We optimize model performance, strengthen governance, and integrate more tightly into operations so AI-driven decisions translate into better service levels, leaner inventory, and reduced risk.
What we enable
A production-grade AI platform with unified SDK and API access that combines:
- Agent orchestration
- Multimodal retrieval
- Built-in evaluation frameworks
- Confidence-based human-in-the-loop routing
- End-to-end production observability
Outcomes
- More reliable, defensible AI-driven decisions
- Built-in auditability, explainability, and human oversight
- Greater control across GxP workflows, supplier management, and distribution
- Stronger performance across forecast accuracy, disruption response, and working capital efficiency
What we enable
- Structured evaluation frameworks across inventory, logistics, and supplier networks
- Benchmarking against service levels, inventory targets, and disruption response KPIs
- Drift detection and recalibration under real-world conditions
- Controlled autonomy with escalation paths and human oversight
- Closed-loop feedback systems for continuous improvement
Outcomes
- More consistent, defensible agent decisions
- Reduced risk from uncontrolled automation
- Stronger execution across forecasting, disruption response, and inventory management
What we enable
- Unstructured → structured pipelines for batch records, COAs, shipment logs, and supplier documents
- Domain-specific labeling for batch IDs, expiry, temperature excursions, and quality events
- Data quality monitoring to detect gaps, inconsistencies, and schema drift
- End-to-end data lineage to support auditability and compliance
- Feedback loops to continuously improve data accuracy
Outcomes
- Higher-quality inputs for AI systems
- Stronger compliance and audit readiness
- More consistent decisions across workflows
- Faster response to disruptions, quality events, and demand shifts
What we enable
- Evaluation frameworks for AI-driven planning and execution
- Benchmarking across forecast accuracy, resilience, and decision reliability
- End-to-end auditability for regulated workflows
- Continuous monitoring for drift and performance degradation
Outcomes
- Reduced regulatory and operational exposure
- More predictable, defensible decisions
- Sustained performance across global supply chain networks
Turn AI Performance into Measurable Outcomes
Real value from AI comes from how systems are evaluated, integrated, and governed in production. We work with pharma supply chain teams to identify where performance gaps exist, align AI outputs with operational decisions, and continuously improve results over time. Our approach focuses on the core levers that determine whether AI drives measurable impact in pharma workflows.
This is how we translate investment into operational and financial outcomes.
AI in Pharma Resources
Stay updated with perspectives on AI implementation, governance, and real-world outcomes.
.avif)
